• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PreserFlo微分流植入术和小梁切除术后眼生物测量的变化:一项前瞻性观察研究。

Changes in Ocular Biometry Following PreserFlo MicroShunt Implantation and Trabeculectomy: A Prospective Observational Study.

作者信息

Nakakura Shunsuke, Oogi Satomi, Terao Etsuko, Nagata Yuki, Fujisawa Yasuko, Dote Saki, Ueda Kanae

机构信息

Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, JPN.

出版信息

Cureus. 2024 Mar 14;16(3):e56188. doi: 10.7759/cureus.56188. eCollection 2024 Mar.

DOI:10.7759/cureus.56188
PMID:38487650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10940033/
Abstract

Background This study aimed to evaluate postoperative changes in ocular biometry following initial PreserFlo MicroShunt implantation and trabeculectomy. Methodology This prospective, observational study analyzed 27 cases of PreserFlo MicroShunt implantation and 29 cases of trabeculectomy performed by a single surgeon. Visual acuity, intraocular pressure, corneal curvature, central corneal thickness, anterior chamber depth, and axial length were assessed at baseline and postoperatively at one day, one week, two weeks, one month, two months, three months, and six months. Patients requiring additional surgery and those with missing data were excluded. Consecutive data were compared with the baseline values using multiple comparisons. Results In both groups, intraocular pressure was significantly decreased from baseline at all postoperative time points (all p < 0.01). Visual acuity decreased in both groups at one day and one week postoperatively. Corneal curvature remained unchanged in both groups throughout the six-month follow-up. Central corneal thickness increased at one day and one week postoperatively in the PreserFlo group, but not in the trabeculectomy group. Anterior chamber depth exhibited a significant decrease at one week postoperatively in both groups. Axial length significantly decreased postoperatively until three months in the PreserFlo group and at all postoperative time points in the trabeculectomy group. Conclusions Ocular biometry following PreserFlo and trabeculectomy had a similar tendency postoperatively.

摘要

背景 本研究旨在评估初次PreserFlo微型分流器植入术和小梁切除术后眼生物测量的变化。方法 这项前瞻性观察性研究分析了由单一外科医生进行的27例PreserFlo微型分流器植入术和29例小梁切除术。在基线以及术后1天、1周、2周、1个月、2个月、3个月和6个月评估视力、眼压、角膜曲率、中央角膜厚度、前房深度和眼轴长度。排除需要额外手术的患者和有缺失数据的患者。使用多重比较将连续数据与基线值进行比较。结果 在两组中,所有术后时间点的眼压均较基线显著降低(所有p < 0.01)。两组术后1天和1周时视力均下降。在整个6个月的随访期间,两组的角膜曲率均保持不变。PreserFlo组术后1天和1周时中央角膜厚度增加,而小梁切除组未增加。两组术后1周时前房深度均显著降低。PreserFlo组术后直至3个月眼轴长度显著缩短,小梁切除组在所有术后时间点眼轴长度均显著缩短。结论 PreserFlo和小梁切除术后眼生物测量术后有相似趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d39ee80c879b/cureus-0016-00000056188-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/bd444064efe5/cureus-0016-00000056188-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d6d08113919e/cureus-0016-00000056188-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/640047503393/cureus-0016-00000056188-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d530afc78847/cureus-0016-00000056188-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/8f16831c953b/cureus-0016-00000056188-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d39ee80c879b/cureus-0016-00000056188-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/bd444064efe5/cureus-0016-00000056188-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d6d08113919e/cureus-0016-00000056188-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/640047503393/cureus-0016-00000056188-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d530afc78847/cureus-0016-00000056188-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/8f16831c953b/cureus-0016-00000056188-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a42e/10940033/d39ee80c879b/cureus-0016-00000056188-i06.jpg

相似文献

1
Changes in Ocular Biometry Following PreserFlo MicroShunt Implantation and Trabeculectomy: A Prospective Observational Study.PreserFlo微分流植入术和小梁切除术后眼生物测量的变化:一项前瞻性观察研究。
Cureus. 2024 Mar 14;16(3):e56188. doi: 10.7759/cureus.56188. eCollection 2024 Mar.
2
Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.英国PreserFlo与小梁切除术治疗青光眼的临床疗效及成本分析
Ophthalmol Glaucoma. 2023 Jul-Aug;6(4):342-357. doi: 10.1016/j.ogla.2022.11.006. Epub 2022 Nov 23.
3
Changes to Corneal Topography and Biometrics After PRESERFLO Microshunt Surgery for Glaucoma.青光眼 PRESERFLO 微分流手术对角膜地形和生物测量的影响。
J Glaucoma. 2021 Oct 1;30(10):921-931. doi: 10.1097/IJG.0000000000001912.
4
Device-modified trabeculectomy for glaucoma.器械改良小梁切除术治疗青光眼。
Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD010472. doi: 10.1002/14651858.CD010472.pub3.
5
Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis.比较 Preserflo Microshunt 植入术和小梁切除术治疗青光眼的安全性和疗效:系统评价和荟萃分析。
Acta Ophthalmol. 2024 Jun;102(4):e443-e451. doi: 10.1111/aos.16658. Epub 2024 Feb 20.
6
Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study.原发性开角型青光眼滤过术后失败眼应用 PreserFlo 微导管的疗效和安全性:一项回顾性研究。
Adv Ther. 2021 Aug;38(8):4403-4412. doi: 10.1007/s12325-021-01811-w. Epub 2021 Jul 12.
7
Early post-operative anterior segment parameters modifications induced by PreserFlo MicroShunt in primary open-angle glaucoma.原发性开角型青光眼术后早期前节参数的改变与 PreserFlo MicroShunt 的关系。
Int Ophthalmol. 2023 Sep;43(9):3035-3044. doi: 10.1007/s10792-023-02697-z. Epub 2023 Apr 8.
8
Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony.术中初次部分阻断 PreserFlo 微分流管以预防术后早期低眼压。
Int Ophthalmol. 2023 Aug;43(8):2643-2651. doi: 10.1007/s10792-023-02664-8. Epub 2023 Mar 11.
9
PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.PreserFlo™ 微分流器与小梁切除术治疗中重度开角型青光眼患者:单中心前瞻性研究的12个月随访
Cureus. 2022 Aug 23;14(8):e28288. doi: 10.7759/cureus.28288. eCollection 2022 Aug.
10
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.青光眼患者中 PreserFlo 微分流管失败后的开放式滤过泡修复手术的结果。
J Glaucoma. 2023 Aug 1;32(8):681-685. doi: 10.1097/IJG.0000000000002246. Epub 2023 Jun 14.

引用本文的文献

1
Factors Affecting Bleb Morphology and Postoperative Intraocular Pressure in Inferotemporal PreserFlo MicroShunt Implantation.影响颞下象限PreserFlo微分流植入术中滤过泡形态及术后眼压的因素
Transl Vis Sci Technol. 2025 Jun 2;14(6):32. doi: 10.1167/tvst.14.6.32.

本文引用的文献

1
Minimally Invasive Glaucoma Surgery: Latest Developments and Future Challenges.微创青光眼手术:最新进展与未来挑战。
Asia Pac J Ophthalmol (Phila). 2023;12(6):537-564. doi: 10.1097/APO.0000000000000646. Epub 2023 Nov 27.
2
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study.外引流微管植入术与小梁切除术治疗原发性开角型青光眼:一项随机、多中心研究的两年结果。
Ophthalmology. 2024 Mar;131(3):266-276. doi: 10.1016/j.ophtha.2023.09.023. Epub 2023 Sep 27.
3
Long-term Outcomes of PreserFlo MicroShunt versus XEN45 Gel Stent in Open-Angle Glaucoma.
保适福微导管与 XEN45 凝胶支架治疗开角型青光眼的长期疗效。
Klin Monbl Augenheilkd. 2024 Jul;241(7):805-812. doi: 10.1055/a-2152-8455. Epub 2023 Sep 6.
4
Minimally Invasive Glaucoma Surgery: A Review of the Literature.微创青光眼手术:文献综述
Vision (Basel). 2023 Aug 21;7(3):54. doi: 10.3390/vision7030054.
5
Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.青光眼患者中 PreserFlo 微分流管失败后的开放式滤过泡修复手术的结果。
J Glaucoma. 2023 Aug 1;32(8):681-685. doi: 10.1097/IJG.0000000000002246. Epub 2023 Jun 14.
6
PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.PRESERFLO ™ 微分流管与小梁切除术:疗效和安全性的 1 年结果。
Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2901-2915. doi: 10.1007/s00417-023-06075-4. Epub 2023 May 3.
7
Early postoperative visual acuity changes after trabeculectomy and factors affecting visual acuity.术后早期小梁切除术后视力变化及影响视力的因素。
Graefes Arch Clin Exp Ophthalmol. 2023 Sep;261(9):2611-2623. doi: 10.1007/s00417-023-06076-3. Epub 2023 Apr 27.
8
Early post-operative anterior segment parameters modifications induced by PreserFlo MicroShunt in primary open-angle glaucoma.原发性开角型青光眼术后早期前节参数的改变与 PreserFlo MicroShunt 的关系。
Int Ophthalmol. 2023 Sep;43(9):3035-3044. doi: 10.1007/s10792-023-02697-z. Epub 2023 Apr 8.
9
Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma.正在发展中的结膜下滤过术:关于MicroShunt植入治疗青光眼患者的当前证据。
Eye Vis (Lond). 2023 Mar 2;10(1):10. doi: 10.1186/s40662-022-00322-1.
10
Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature.PRESERFLO 微型分流器的疗效及文献荟萃分析
J Clin Med. 2022 Dec 1;11(23):7149. doi: 10.3390/jcm11237149.